Researchers have identified a protein likely to be involved in the exacerbation of chronic obstructive pulmonary disease (COPD). This protein, Siglec-14, could serve as a potential new target for ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued a warning in 2019 about serious breathing problems associated with gabapentinoids. The study ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...

If you have COPD, there are some things that can cause the disease to flare up. This is referred to as “COPD exacerbation.” Some of the most common causes of COPD exacerbation include: When you have ...

A pilot study shows digital inhaler data can detect early signs of COPD exacerbations, offering promise for proactive disease ...

Zhu D, Dai H, Zhu H, et al. Identification of frequent acute exacerbations phenotype in COPD patients based on imaging and clinical characteristics. Respiratory Medicine . Published online ...

There is increasing evidence that the CAT is a promising tool to quantify COPD exacerbations. Accordingly, the CAT score can be a useful marker in clinical trials that evaluate the effectiveness ...

In a phase 3, double-blind, randomized, placebo-controlled trial, patients with COPD, a history of exacerbations, and a blood eosinophil count of at least 300 cells per microliter who were ...

pneumococcal polyvalent vaccine-23. SAN DIEGO — Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple therapy, according to a ...

Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test (CAT), according to a new study from the UK. "There is ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil ...